ZoBio and Domainex Ltd. announce a collaboration with FORMA Therapeutics to provide NMR-based structural biology services for a substantial panel of FORMA drug targets.
8th December 2014
3rd December 2014
Novel approach to treating asthma: Neutralize the trigger
15th October 2014
Cambridge, UK and Sydney, Australia - 15 October 2014 - Domainex Ltd. and Auspherix Pty Ltd today announced a collaboration that will progress Auspherix’s novel anti-infective drug discovery programme towards the nomination of a clinical c
9th July 2014
Domainex today announced a potent lead compound in a model of COPD and has also won a £1.4m Biomedical Catalyst Award for Phase I clinical studies
1st June 2014
Domainex Ltd. has successfully completed in-vivo studies examining its proprietary selective inhibitors of IKK-epsilon and TBK1 in inflammation models.
7th April 2014
Domainex programme shows great promise for the treatment of inflammatory diseases, such as Chronic Obstructive Pulmonary Disease (COPD).